Cadrenal Therapeutics, Inc. (CVKD)

NASDAQ: CVKD · Real-Time Price · USD

6.52

-0.45 (-6.46%)

At close: Mar 20, 2026, 4:00 PM EDT

6.48

-0.04 (-0.65%)

After-hours: Mar 20, 2026, 6:58 PM EDT

Cadrenal Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-14.39	-10.65	-8.36
Depreciation & Amortization	0.01	0	0
Stock-Based Compensation	2.38	1.42	0.71
Other Adjustments	-0	-0	3.97
Changes in Accounts Payable	0.12	1.34	-0.24
Changes in Accrued Expenses	-0.03	0.54	-0.23
Changes in Other Operating Activities	0.07	-0.01	0.61
Operating Cash Flow	-11.82	-7.36	-3.53
Capital Expenditures	-0.01	-0.01	-0
Investing Cash Flow	-0.01	-0.01	-0
Long-Term Debt Repaid	-	-	-0.25
Net Long-Term Debt Issued (Repaid)	-	-	-0.25
Issuance of Common Stock	7.56	9.86	12.15
Net Common Stock Issued (Repurchased)	7.56	9.86	12.15
Other Financing Activities	-0.41	-0.88	-
Financing Cash Flow	11.33	8.98	11.9
Net Cash Flow	-0.5	1.62	8.37
Free Cash Flow	-11.84	-7.36	-3.53
Free Cash Flow Per Share	-6.74	-6.04	-3.93
Levered Free Cash Flow	-14.24	-8.78	-8.46
Unlevered Free Cash Flow	-14.53	-9.09	-7.49

Updated Nov 10, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q